| Detected | Trial | Change |
|---|---|---|
| 2026-07-24 | NCT07632365 Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation… |
overall status: Active, Not Recruiting → Recruiting |
| 2026-07-24 | NCT07632365 Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation… |
Enrollment increased: 30 -> 108 participants |
| 2026-07-24 | NCT07632365 Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation… |
Trial arms changed: 3 -> 2 |
| 2026-07-24 | NCT07632365 Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation… |
date change Primary completion pushed: 2026-05-30 -> 2028-12-31 |
| 2026-07-24 | NCT07632365 Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation… |
date change Completion pushed: 2027-11-30 -> 2028-12-31 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06483009 | Efficacy and Safety of Combination Therapy of Sintilimab and Chemotherapy With… | Non-Small-Cell Lung Cancer | Not Yet Recruiting |
| Phase 3 | |||
| NCT04135664 | Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage… | Esophageal Cancer | Recruiting |
| NCT06437977 | Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable… | Stage II-III Non-small Cell Lung Cancer | Recruiting |
| Phase 2/3 | |||
| NCT07076693 | Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With… | OligoProgressive Metastatic Disease | Active, Not Recruiting |
| NCT07662811 | SYHX2011 in Combination With Carboplatin and Enlonstobart as First-Line Therapy for… | Non-Small Cell Lung Cancer | Not Yet Recruiting |
| Phase 2 | |||
| NCT06385730 | Neoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS) | Esophageal Cancer | Recruiting |
| NCT06698965 | Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer… | Lung Cancer, Small Cell | Recruiting |
| NCT06709417 | A Phase II Clinical Study of Sintilimab Combined with Chemotherapy Followed by Concurrent… | Esophageal Squamous Cell Carcinoma (ESCC) | Recruiting |
| NCT06659042 | Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small… | Lung Cancer, Non-Small Cell | Recruiting |
| NCT06127303 | Toripalimab Combined With Cryoablation for First-line Oligo-progression in… | Non-small Cell Lung Cancer | Recruiting |
| NCT07058519 | A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC | Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC) | Recruiting |
| NCT05978193 | Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell… | Esophageal Squamous Cell Carcinoma | Recruiting |
| NCT07357623 | Surufatinib Combined With Chemo Versus Surufatinib in the Treatment of Pulmonary… | Pulmonary Neuroendocrine Tumor | Recruiting |
| NCT05798845 | The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+)… | NSCLC | Recruiting |
| NCT07091305 | A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy… | Limited-stage Small Cell Lung Cancer (LS-SCLC) | Recruiting |
| NCT06178211 | Neoadjuvant Adebrelimab Plus Chemotherapy for Resectable ESCC: a Single Arm, Prospective… | Esophageal Squamous Cell Carcinoma | Not Yet Recruiting |
| NCT06469060 | Neoadjuvant Immunochemotherapy for Adenocarcinoma of the Esophagogastric Junction | Esophageal Cancer | Not Yet Recruiting |
| NCT06688656 | Neoadjuvant Chemotherapy Sequentially Combined with Sintilimab in Resectable EGFR-Mutant… | Lung Cancer | Not Yet Recruiting |
| NCT06936644 | A Multicenter, Single-arm Phase II Study to Evaluate the Efficacy and Safety of… | KRAS G12C Lung Cancer | Not Yet Recruiting |
| NCT06965829 | The Effect of Neoadjuvant Chemoimmnotherapy Combined With Node Sparing Radiotherapy for… | Esophageal Cancer Stage III | Not Yet Recruiting |
| NCT06982924 | A Clinical Study on the Efficacy and Safety of the Combination of Limertinib and… | EGFR Mutation Positive Advanced Non Small Cell Lung Cancer | Not Yet Recruiting |
| NCT05078931 | A Study to Evaluate Pembrolizumab Plus Lenvatinib in PD-L1 Positive TKI Resistant NSCLC… | NSCLC | Active, Not Recruiting |
| NCT04504071 | Dacomitinib in Lung Cancer With Uncommon EGFR Mutations | Non-small Cell Lung Cancer Metastatic | Active, Not Recruiting |
| NCT07261098 | The Efficacy and Safety of ARNI on the Outcome of Advanced Lung Cancer With Concurrent… | Advanced Lung Cancer | Not Yet Recruiting |
| NCT07281209 | A Study of SHR-A1811 Combined With Adebelimumab as Neoadjuvant Therapy for Resectable… | NSCLC | Not Yet Recruiting |